Monthly open-access biomedical journal by the American Medical Association
Two 14-year-old boys in Pennsylvania admitted to creating hundreds of AI-generated images of classmates, including minors. The case highlights legal uncertainties around AI crimes involving minors, delayed school response, and ongoing efforts to regulate deepfake technology. Victims report trauma and community impact.
UK study shows GLP-1 drugs are changing spending patterns. The first oral pill in the category has been approved, and uptake could rise from about 3 million to 7 million by 2027. Private use remains common, with shifts toward nutrition, fitness, and fresh food.
A Japanese approval for Telomelysin offers a gentler option for esophageal cancer patients ineligible for surgery. Other studies show CAR T-cell therapy remains transformative for certain cancers, while nanotechnology and immunotherapies highlight ongoing progress with meaningful patient impact.
A JAMA Network Open study finds the vaccine reduces COVID-19-related hospitalizations by about 55% and lowers visits to emergency departments by 50%. The paper has drawn attention because of past political interference in CDC publishing decisions. The study uses a test-negative design and is part of ongoing assessments of vaccine performance amid evolving viral strains.